Αρχική World News FDA Approves Durvalumab for Limited-Stage Small Cell Lung Cancer World News FDA Approves Durvalumab for Limited-Stage Small Cell Lung Cancer Από Ogkologos - 17 Ιανουαρίου, 2025 954 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the ADRIATIC study Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ Ahead of the Special European Council Meeting on 26-27 November, ESMO Calls on EU Governments to Continue Support for the Cancer Mission European Parliament backs key priorities advocated by ESMO for cancer research and innovation FDA approves giredestrant in combination with everolimus for ER-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer MOST POPULAR Clinical Trials in Genitourinary Cancers: CheckMate 914, KEYNOTE-992, and KEYNOTE-991 20 Μαΐου, 2021 Atezolizumab Plus Bevacizumab Approved to Treat Liver Cancer 4 Ιουνίου, 2020 Does Sugar Feed Cancer? 19 Μαρτίου, 2021 Science Surgery: ‘Can cancers develop in the heart?’ 30 Μαρτίου, 2021 Φόρτωση περισσοτέρων HOT NEWS Do Frequent Follow-Up Tests Benefit Colorectal Cancer Survivors? How to Improve Cancer-Related Fatigue Using Exercise: Expert Perspectives FDA Approves Gedatolisib with Fulvestrant, With or Without Palbociclib, for HR-positive,... As Winter Storms Plague Southern States, GreaterGood Is Helping Where It’s...